IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results.
- IRIDEX and Cutera Close Acquisition of IRIDEX' Aesthetic Business Unit. Read more
- MicroPulse™ Laser Therapy Enhances Visual Function in Patients with CSC. Read More
- IRIDEX presents at the 2012 Roth Conference. Download presentation.
- Jul 26 - Jul 28 - SE Eye 2012 - Destin, FL
- Aug 25 - Aug 29 - ASRS - Las Vegas, NV
IRIDEX Ophthalmology laser systems help treat the three leading causes of irreversible blindness: age-related macular degeneration, diabetic retinopathy, and glaucoma. Otologists use our laser systems to perform stapedotomy and stapedectomy procedures which successfully correct various types of hearing loss. IRIDEX lasers also help veterinary ophthalmologists treat glaucoma, tumors, cysts, and retinal disorders